Patents by Inventor Solomon R. Pollack

Solomon R. Pollack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8137972
    Abstract: Scaffolds for tissue engineering prepared from biocompatible, biodegradable polymer-based, lighter than or light as water microcarriers and designed for cell culturing in vitro in a rotating bioreactor are provided. Methods for preparation and use of these scaffolds as tissue engineering devices are also provided.
    Type: Grant
    Filed: May 30, 2007
    Date of Patent: March 20, 2012
    Assignees: Drexel University, The Wistar Institute, The Trustees Of The University of Pennsylvania
    Inventors: Cato T. Laurencin, Solomon R. Pollack, Elliot Levine, Edward Botchwey, Helen H. Lu, Mohammed Yusuf Khan
  • Publication number: 20120016442
    Abstract: Methods and devices for the regulation of gene expression by cells via the application of fields generated by specific and selective electric and electromagnetic signals so as to target diseased or injured tissue for treatment. By gene expression is meant the up regulation or down regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein. Methods and devices are provided for the targeted treatment of injured or diseased tissue that include providing specific and selective electric and electromagnetic signals and exposing tissue to the fields generated by the signals so as to regulate gene expression. In particular, methods and devices are provided for the targeted treatment of bone defects, osteoarthritis, osteoporosis, cancer, and other disease states.
    Type: Application
    Filed: September 23, 2011
    Publication date: January 19, 2012
    Applicant: The Trustees of the University of Pennsylvania
    Inventors: Carl T. Brighton, Solomon R. Pollack
  • Patent number: 8065015
    Abstract: Methods and devices for the regulation of gene expression by cells via the application of fields generated by specific and selective electric and electromagnetic signals so as to target diseased or injured tissue for treatment. By gene expression is meant the up regulation or down regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein. Methods and devices are provided for the targeted treatment of injured or diseased tissue that include providing specific and selective electric and electromagnetic signals and exposing tissue to the fields generated by the signals so as to regulate gene expression. In particular, methods and devices are provided for the targeted treatment of bone defects, osteoarthritis, osteoporosis, cancer, and other disease states.
    Type: Grant
    Filed: July 3, 2008
    Date of Patent: November 22, 2011
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Carl T. Brighton, Solomon R. Pollack
  • Publication number: 20090062885
    Abstract: A method of determining the voltage and current required for the application of specific and selective electric and electromagnetic signals to diseased articular cartilage in the treatment of osteoarthritis, cartilage defects due to trauma or sports injury, or used as an adjunct with other therapies (cell transplantation, tissue-engineered scaffold, growth factors, etc.) for treating cartilage defects in the human hip joint and a device for delivering such signals to a patient's hip. Anatomic, analytical, and planar circuit models are developed to determining the impedances, conductivities, and current flows in the human hip joint and its surrounding soft tissues and skin that are required to produce a 20 mV/cm electric field in the synovium and articular cartilage of the human hip. The voltage of the signal applied to the surface electrodes or to a coil(s) or solenoid is varied based on the size of the hip joint; larger hip joints require larger voltages to generate the effective electric field.
    Type: Application
    Filed: November 12, 2004
    Publication date: March 5, 2009
    Inventors: Carl T. Brighton, Solomon R. Pollack
  • Patent number: 7468264
    Abstract: A method of determining the voltage and current output required for the application of specific and selective electric and electromagnetic signals to diseased articular cartilage in the treatment of osteoarthritis, cartilage defects due to trauma or sports injury, or used as an adjunct with other therapies (cell transplantation, tissue-engineered scaffolds, growth factors, etc.) for treating cartilage defects in the human knee joint and a device for delivering such signals to a patient's knee. An analytical model of the human knee is developed whereby the total tissue volume in the human knee may be determined for comparison to the total tissue volume of the diseased tissue in the animal model using electric field and current density histograms.
    Type: Grant
    Filed: April 4, 2006
    Date of Patent: December 23, 2008
    Assignee: The Trustees Of The University Of Pennsylvania
    Inventors: Carl T. Brighton, Solomon R. Pollack
  • Patent number: 7465566
    Abstract: Methods and devices for the regulation of gene expression by cells via the application of fields generated by specific and selective electric and electromagnetic signals so as to target diseased or injured tissue for treatment. By gene expression is meant the up regulation or down regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein. Methods and devices are provided for the targeted treatment of injured or diseased tissue that include providing specific and selective electric and electromagnetic signals and exposing tissue to the fields generated by the signals so as to regulate gene expression. In particular, methods and devices are provided for the targeted treatment of bone defects, osteoarthritis, osteoporosis, cancer, and other disease states.
    Type: Grant
    Filed: February 22, 2001
    Date of Patent: December 16, 2008
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Carl T. Brighton, Solomon R. Pollack
  • Publication number: 20080269838
    Abstract: Methods and devices for the regulation of gene expression by cells via the application of fields generated by specific and selective electric and electromagnetic signals so as to target diseased or injured tissue for treatment. By gene expression is meant the up regulation or down regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein. Methods and devices are provided for the targeted treatment of injured or diseased tissue that include providing specific and selective electric and electromagnetic signals and exposing tissue to the fields generated by the signals so as to regulate gene expression. In particular, methods and devices are provided for the targeted treatment of bone defects, osteoarthritis, osteoporosis, cancer, and other disease states.
    Type: Application
    Filed: July 3, 2008
    Publication date: October 30, 2008
    Applicant: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: Carl T. Brighton, Solomon R. Pollack
  • Patent number: 7215995
    Abstract: A method of determining the voltage and current required for the application of specific and selective electric and electromagnetic signals to diseased articular cartilage in the treatment of osteoarthritis, cartilage defects due to trauma or sports injury, or used as an adjunct with other therapies (cell transplantation, tissue-engineered scaffold, growth factors, etc.) for treating cartilage defects in the human hip joint and a device for delivering such signals to a patient's hip. Anatomic, analytical, and planar circuit models are developed to determining the impedances, conductivities, and current flows in the human hip joint and its surrounding soft tissues and skin that are required to produce a 20 mV/cm electric field in the synovium and articular cartilage of the human hip. The voltage of the signal applied to the surface electrodes or to a coil(s) or solenoid is varied based on the size of the hip joint; larger hip joints require larger voltages to generate the effective electric field.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: May 8, 2007
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Carl T. Brighton, Solomon R. Pollack
  • Patent number: 7167753
    Abstract: A technique and associated device for stimulating multiple electrodes with multiple electrical signals in multiple regions of the spine without injury to the patient. The electrodes are applied to respective sides of the patient's spine, and a first electrical signal is applied to any electrodes in a treatment area of the lumbar region of the patient's spine, a second electrical signal is applied to any electrodes in a treatment area of the thoracic region of the patient's spine, and a third electrical signal is applied to any electrodes in a treatment area of the cervical region of the patient's spine to induce osteogenesis in at least one of the respective treated area's of the patient's spine. The first, second, and third electrical signals respectively generate different electrode currents in the respective treated areas and are ideally selected to create current densities that are approximately equal in respective treatment areas.
    Type: Grant
    Filed: July 2, 2002
    Date of Patent: January 23, 2007
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Carl T Brighton, Solomon R Pollack
  • Patent number: 7158835
    Abstract: A technique and device for preventing and/or treating osteoporosis, hip and spine fractures, and/or spine fusions by incorporating at least one conductive coil (110) into a garment (90) adapted to be worn adjacent to the patient's skin over a treatment area and applying an electrical signal to the coil effective to produce a magnetic flux the penetrates the treatment area so as to produce an electric field in the bones and the treatment area.
    Type: Grant
    Filed: July 10, 2002
    Date of Patent: January 2, 2007
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Carl T. Brighton, Solomon R. Pollack
  • Patent number: 7022506
    Abstract: A method of determining the voltage and current output required for the application of specific and selective electric and electromagnetic signals to diseased articular cartilage in the treatment of osteoarthritis, cartilage defects due to trauma or sports injury, or used as an adjunct with other therapies (cell transplantation, tissue-engineered scaffolds, growth factors, etc.) for treating cartilage defects in the human knee joint and a device for delivering such signals to a patient's knee. An analytical model of the human knee is developed whereby the total tissue volume in the human knee may be determined for comparison to the total tissue volume of the diseased tissue in the animal model using electric field and current density histograms.
    Type: Grant
    Filed: June 9, 2003
    Date of Patent: April 4, 2006
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Carl T. Brighton, Solomon R. Pollack
  • Publication number: 20040006373
    Abstract: A method of determining the voltage and current output required for the application of specific and selective electric and electromagnetic signals to diseased articular cartilage in the treatment of osteoarthritis, cartilage defects due to trauma or sports injury, or used as an adjunct with other therapies (cell transplantation, tissue-engineered scaffolds, growth factors, etc.) for treating cartilage defects in the human knee joint and a device for delivering such signals to a patient's knee. An analytical model of the human knee is developed whereby the total tissue volume in the human knee may be determined for comparison to the total tissue volume of the diseased tissue in the animal model using electric field and current density histograms.
    Type: Application
    Filed: June 9, 2003
    Publication date: January 8, 2004
    Applicant: The Trustees of the University of Pennsylvania
    Inventors: Carl T. Brighton, Solomon R. Pollack
  • Publication number: 20030211084
    Abstract: Methods and devices (10) for the regulation of gene expression by cells via the application of specific and selective electric and electromagnetic signals so as to target diseased or injured tissue for treatment. Gene expression is the up regulation or down regulation of the process whereby specific portions, genes of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein.
    Type: Application
    Filed: October 8, 2002
    Publication date: November 13, 2003
    Inventors: Carl T Brighton, Solomon R Pollack
  • Publication number: 20020155559
    Abstract: Scaffolds for tissue engineering prepared from biocompatible, biodegradable polymer-based, lighter than or light as water microcarriers and designed for cell culturing in vitro in a rotating bioreactor are provided. Methods for preparation and use of these scaffolds as tissue engineering devices are also provided.
    Type: Application
    Filed: January 17, 2002
    Publication date: October 24, 2002
    Inventors: Cato T. Laurencin, Solomon R. Pollack, Elliot Levine, Edward Botchwey, Helen H. Lu, Mohammed Yusuf Khan
  • Patent number: 5014699
    Abstract: A non-invasive, portable electromagnetic therapeutic method and apparatus for promoting the healing of damaged or diseased living tissue including fractured bone and in particular nonunion or delayed union bone fractures are described. The method and apparatus involve generating a signal having a series of substantially symmetric voltage cycles of bursted pulses having narrow pulse widths on the order of 0.5 to 20 microseconds and converting the signal into an electromagnetic field which extends into an area for desired tissue healing. The portable noninvasive apparatus can be readily worn or carried by a patient and is capable of generating an energy-efficient symmetrical signal coacting with a coil for transducing the signal into electromagnetic pulses.
    Type: Grant
    Filed: November 30, 1989
    Date of Patent: May 14, 1991
    Assignee: Trustees of the University of Pennsylvania
    Inventors: Solomon R. Pollack, Carl T. Brighton, David Pienkowski, Neil J. Griffith
  • Patent number: 4535775
    Abstract: Bone fractures previously considered incurable are healed non-invasively by applying to electrodes coupled to the skin of a living body in the vicinity of a bone fracture an alternating voltage having a wave form that is symmetrical with respect to the axis, a frequency in the range 20-100 KHz and a value in the range from about 2 to 10 volts peak to peak.
    Type: Grant
    Filed: February 10, 1983
    Date of Patent: August 20, 1985
    Assignee: Biolectron, Inc.
    Inventors: Carl T. Brighton, Solomon R. Pollack
  • Patent number: 4467808
    Abstract: Osteoporosis in a living body prevented and/or treated by applying electrodes non-invasively to a body and supplying to the electrodes an AC signal of about 5-15 volts peak-to-peak at a frequency of about 20-100 KHz to cause a treatment current to flow in a body region affected or likely to be affected by osteoporosis.
    Type: Grant
    Filed: September 17, 1982
    Date of Patent: August 28, 1984
    Assignee: Biolectron, Inc.
    Inventors: Carl T. Brighton, Solomon R. Pollack